Decoy Therapeutics DCOY
NASDAQ DCOY
$1.77 -0.09 (-4.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Decoy Therapeutics (DCOY) Return on Assets [ROA] (2015 - 2026)

Updated

Decoy Therapeutics (DCOY) posted Return on Assets [ROA] of -169.46% for Q2 2026, up 105.35 percentage points from -274.81% a year earlier but down 35.06 percentage points from the prior quarter.

Analysis

Decoy Therapeutics (DCOY) Return on Assets [ROA] (2015 - 2026) Analysis & Trends

For FY2025, Decoy Therapeutics' Return on Assets [ROA] came in at -179.18%, down 59.83 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -141.31 percentage points (FY2020 to FY2025).
  • In prior years, Decoy Therapeutics' Return on Assets [ROA] was -119.35% in FY2024 (+2.09 pp), -121.44% in FY2023 (-6.66 pp), -114.77% in FY2022 (-75.81 pp) and -38.97% in FY2021 (-1.09 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -274.81% in Q2 2025 to a high of -22.76% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last four quarters, with an average year-over-year change of +9.18 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2024, with a gain of 116.98 percentage points; the weakest was Q2 2023, with a drop of 218.21 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -134.40% (Q1 2026), -146.62% (Q4 2025) and -134.30% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Decoy Therapeutics 941,583.35 941,583.35 - -169.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -169.46%
Mar 31, 2026 -134.40%
Dec 31, 2025 -146.62%
Sep 30, 2025 -134.30%
Jun 30, 2025 -274.81%
Mar 31, 2025 -208.67%
Dec 31, 2024 -162.76%
Sep 30, 2024 -137.13%
Jun 30, 2024 -155.34%
Mar 31, 2024 -157.04%
Dec 31, 2023 -168.53%
Sep 30, 2023 -177.31%
Jun 30, 2023 -272.32%
Mar 31, 2023 -250.52%
Dec 31, 2022 -184.53%
Sep 30, 2022 -110.09%
Jun 30, 2022 -54.10%
Mar 31, 2022 -44.71%
Dec 31, 2021 -30.10%
Sep 30, 2021 -22.76%
API Access

Decoy Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DCOY&period=max&api_key=YOUR_API_KEY